Hyperbaric Oxygen Therapy in Acute Ischemic Stroke Ischemic Stroke Recovery (Pro00061930)
Recruiting now · Not applicable
Conditions studied: Acute Ischemic Stroke
In brief
This study will critically examine the feasibility, safety and efficacy of HBOT during inpatient rehabilitation (IPR) after acute ischemic stroke measured by non-disruption of 3 hours of daily therapy, frequency of neurological deterioration or complications (seizure, hemorrhage, brain edema), and functional communication, activities of daily living (ADLs) and mobility.
Key facts
- Study ID
- NCT06148285
- Run by
- LCMC Health
- People needed
- 120
- Starts
- 2022-05-24
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2023-11-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years and above
- Ischemic stroke proven on neuroimaging
- Within 7-30 days post-stroke on day 1 of treatment
- Admitted to Touro Inpatient Rehab Facility
You may not qualify if…
- Pre-stroke modified Rankin Scale Score >2
- Parenchymal hemorrhagic transformation (PH1 or PH2)
- Receptive aphasia such that recommendations for preventative measures to mitigate barotrauma cannot be followed
- History of recurrent and unprovoked seizures requiring a change in management in the last 3 months to control seizures
- Pulmonary disease requiring supplemental oxygen or daily respiratory medication management (metered dose inhalers, nebulized treatment or steroids)
Where it is running
- Touro Infirmary New Orleans — New Orleans, Louisiana, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.